BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT00656617-completion@plaintrial.com
DTSTAMP:20260928T221954Z
DTSTART;VALUE=DATE:201402
SUMMARY:Phase II Study of Idarubicin\, Cytarabine\, and Vorinostat With Hig
 h-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) —
  estimated completion date
DESCRIPTION:Completed. Saved on your PlainTrial shortlist. Full trial recor
 d: https://plaintrial.com/trial/NCT00656617
URL:https://plaintrial.com/trial/NCT00656617
END:VEVENT
END:VCALENDAR